WIA
BNGO icon

Wetzel Investment Advisors’s Bionano Genomics BNGO Stock Holding History

Wetzel Investment Advisors’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2
Closed -$111 – 219
2024
Q2 		$111 Hold
2
– – ﹤0.01% 922
2024
Q1 		$79 Hold
2
– – ﹤0.01% 1030
2023
Q4 		$0 Buy
+2
New +$209 ﹤0.01% 1010

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return

Wetzel Investment Advisors's BNGO Position: Q3 2024 in Review

Wetzel Investment Advisors sold out of Bionano Genomics (BNGO) in Q3 2024, closing a stake of 2 shares — an estimated $111 sold.

Wetzel Investment Advisors first reported a position in BNGO in Q4 2023 and held it in 3 quarters. The position peaked at $111 in Q2 2024. 47 funds tracked by Wall St. Rank hold BNGO as of Q3 2024.

  • Wetzel Investment Advisors reported no remaining Bionano Genomics position as of Q3 2024 after selling out during the quarter.
  • Wetzel Investment Advisors sold 2 Bionano Genomics shares in Q3 2024, an estimated $111.
  • Wetzel Investment Advisors first reported a position in Bionano Genomics in Q4 2023 and held it in 3 quarters.
  • Wetzel Investment Advisors's Bionano Genomics position peaked at $111 in Q2 2024.
  • 47 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2024.

Based on Wetzel Investment Advisors's 13F filing for Q3 2024, filed 29 Oct 2024.